ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.62
0.96%
US Tech 100
18,064.80
0.02%
S&P 500
5,277.51
0.80%
US Dollar vs CAD
1.36535
0.00%
Bitcoin
67,642.39
0.24%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Australia
  5. ASX
  6. Donaco International Ltd (DNA)

  7. Donaco International Ltd (DNA) News

DNA

Donaco (DNA)

Donaco International Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:ASX:DNA
DateTimeSourceHeadlineSymbolCompany
11/10/20155:52PMThe Motley FoolPacker backs Crown Resorts Ltd with $200 million betASX:DNADonaco International Ltd
03/27/200910:13AMDow Jones NewsUPDATE: FDA 'Unclear' If Avastin Data Backs Expanded ApprovalTSXV:DNAGenentech Inc. (Delisted 3/27/09)
03/27/20099:35AMDow Jones NewsFDA 'Unclear' If Genentech Drug Data Backs Expanded ApprovalTSXV:DNAGenentech Inc. (Delisted 3/27/09)
03/26/20094:23AMDow Jones NewsUPDATE: Roche Effectively Seals $46.8 Billion Genentech TakeoverTSXV:DNAGenentech Inc.
03/26/20092:05AMDow Jones NewsRoche Completes Genentech Takeover, Holds 93.2%TSXV:DNAGenentech Inc.
03/26/20091:37AMDow Jones NewsRoche Completes Tender Offer For Genentech, Holds 93.2%TSXV:DNAGenentech Inc.
03/25/20097:44AMDow Jones News2nd UPDATE: Ethos Recommends UBS Holders Reject New Pay PlanTSXV:DNAGenentech Inc.
03/25/20095:43AMDow Jones NewsUPDATE: Ethos Recommends UBS Holders Reject New Pay Plan At AGMTSXV:DNAGenentech Inc.
03/24/20091:08PMDow Jones NewsRoche Says RiskMetrics Backs Genentech Takeover At $95/ShareTSXV:DNAGenentech Inc.
03/19/200912:09PMDow Jones NewsEU Panel Backs Novartis' Glivec In Kit-positive GISTTSXV:DNAGenentech Inc.
03/18/20098:55AMDow Jones NewsRoche Shares Down On Actemra; Herceptin Success Of Little HelpTSXV:DNAGenentech Inc.
03/18/20092:16AMDow Jones NewsRoche's Herceptin Extends Life In Aggressive Stomach CancerTSXV:DNAGenentech Inc.
03/18/20091:33AMDow Jones NewsRoche: Herceptin Prolongs Life In Stomach CancerTSXV:DNAGenentech Inc.
03/17/200911:32PMDow Jones NewsUPDATE: Chugai,Roche Face Arthritis Drug Side Effect SetbackTSXV:DNAGenentech Inc.
03/17/20098:05PMDow Jones NewsChugai:Undeniable Actemra Side Effects Tied To Patient DeathsTSXV:DNAGenentech Inc.
03/17/20095:54PMDow Jones NewsBiotechnology Group Praises Biologic Drugs BillTSXV:DNAGenentech Inc.
03/17/20093:29PMDow Jones News5th UPDATE: Pfizer Sells $13.5 Billion Bond Offering TuesdayTSXV:DNAGenentech Inc.
03/17/20092:25PMDow Jones News4th UPDATE: Pfizer Sells $13.5 Billion Bond Offering TuesdayTSXV:DNAGenentech Inc.
03/17/200912:53PMDow Jones News3rd UPDATE: Pfizer Launches $13.5 Billion Bond Offer; Pricing TuesdayTSXV:DNAGenentech Inc.
03/17/200912:01PMDow Jones News2ndUPDATE:Pfizer Launches $13.5 Billion Bond Offering For Pricing TuesdayTSXV:DNAGenentech Inc.
03/17/200911:13AMDow Jones NewsUPDATE:Pfizer Launches $13.5 Billion Bond Offering For Pricing TuesdayTSXV:DNAGenentech Inc.
03/16/20093:57PMDow Jones NewsMARKET SNAPSHOT: Corporate Cash Reserves, Cheap Stocks Could Trigger More M&ATSXV:DNAGenentech Inc.
03/16/20091:49PMDow Jones NewsMARKET SNAPSHOT: Corporate Cash Warchests, Cheap Stocks Could Trigger More M&ATSXV:DNAGenentech Inc.
03/16/20091:37AMDow Jones NewsRoche Acquires Innovatis AG For EUR15 MillionTSXV:DNAGenentech Inc.
03/13/20097:45AMDow Jones NewsGenentech-Roche Deal Shows Attraction Of Biotech AssetsTSXV:DNAGenentech Inc.
03/12/20093:42PMDow Jones NewsGenentech-Roche Deal Shows Attraction Of Biotech AssetsTSXV:DNAGenentech Inc.
03/12/20092:15PMDow Jones NewsUS Antitrust Review May Not Pose Threat To Drug Co MergersTSXV:DNAGenentech Inc.
03/12/20099:06AMDow Jones NewsUPDATE: Gilead To Buy CV Therapeutics For $1.4 BillionTSXV:DNAGenentech Inc.
03/12/20096:10AMDow Jones News4th UPDATE: Roche Seals $46.8 Billion Genentech DealTSXV:DNAGenentech Inc.
03/12/20093:32AMDow Jones News3rd UPDATE: Roche Seals $46.8 Billion Genentech DealTSXV:DNAGenentech Inc.
 Showing the most relevant articles for your search:ASX:DNA

Your Recent History

USOTC
HMBL
HUMBL (PK)
AMEX
FOXO
FOXO Technologies
USOTC
RSPI
RespireRx Pharmaceuticals (PK)
USOTC
CYDY
CytoDyn (QB)
USOTC
TPTW
TPT Global Tech (PK)
USOTC
DRNK
NoHo (PK)
USOTC
CATV
4Cable TV (PK)
USOTC
IFUS
Impact Fusion (PK)
USOTC
GNCP
GNCC Capital (CE)
NASDAQ
COOP
Mr Cooper
NASDAQ
NB
NioCorp Developments
USOTC
CEOS
CeCors (PK)
NASDAQ
PLUG
Plug Power
USOTC
KEGS
1812 Brewing (PK)
USOTC
RNVA
Rennova Health (PK)
NASDAQ
RVNC
Revance Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved